Friedman v. Medtronic, Inc.

42 A.D.2d 185, 345 N.Y.S.2d 637, 1973 N.Y. App. Div. LEXIS 3789
CourtAppellate Division of the Supreme Court of the State of New York
DecidedJuly 9, 1973
StatusPublished
Cited by40 cases

This text of 42 A.D.2d 185 (Friedman v. Medtronic, Inc.) is published on Counsel Stack Legal Research, covering Appellate Division of the Supreme Court of the State of New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Friedman v. Medtronic, Inc., 42 A.D.2d 185, 345 N.Y.S.2d 637, 1973 N.Y. App. Div. LEXIS 3789 (N.Y. Ct. App. 1973).

Opinion

Latham, J.

On July 10, 1963, a Medtronic model 58-60 implantable pacemaker was surgically placed inside the plaintiff’s body. The purpose of the pacemaker was to provide an electrical charge to the plaintiff’s heart to enable the heart to beat at a regular rate. In September of 1963 the pacemaker ceased to trigger heart contractions. X rays showed that there was a break in the cardiac electro lead approximately at the point the lead entered the heart muscle. The problem was corrected through operative procedure whereby the pacemaker was changed from bi-polar to uni-polar operation, a change contemplated by the pacemaker’s design.

On April 2, 1964 the original pacemaker was removed and a new one inserted. The doctor who removed the first pacemaker [187]*187had stated in the hospital record that the failure of this pacemaker to supply current to the heart was due to fibrosis, a formation of fibrous tissue around the electrode.

On November 17,1964 the plaintiff was readmitted to the hospital. The second pacemaker was supplying an accelerated beat. It was removed and a third pacemaker was implanted.

The plaintiff brought this action against the manufacturer of the pacemakers and the surgeon who had implanted the first pacemaker. The sole cause of action against the surgeon, sounding in negligence, was discontinued during the .trial. A cause of action against the manufacturer, the appellant, based on its alleged negligence, was dismissed at the close of the plaintiff’s case. The action against the appellant was submitted to the jury only upon the theory of breach of implied and express warranties. The jury returned a general verdict in the plaintiff’s favor in the amount of $23,000. The appellant argues that the plaintiff has not made out a prima facie case for breach of warranty. For reasons stated beyond, we reverse the judgment and grant a new trial.

Our initial consideration concerns the issue of implied warranties. The first occurrence complained of is the break of the electrode near its tip, for which corrective surgery was performed on September 15,1963. The evidence at the trial showed that there were at least three possible causes for the breaking of the electrode. There was no testimony from which the jury could have inferred that one possible cause was more likely to have occurred than the others. Since each of the possibilities was just as likely to have occurred as any other, the jury would only have been justified in finding for the plaintiff if the appellant had impliedly warranted against the occurrence of all three. A jury cannot speculate upon probabilities (Blaikie v. Post, 137 App. Div. 648, 651). Where' there are several possible theories to explain the happening of an event, the evidence must be such as to have selective application as to the one adopted by the fact-finder; two or more plausible explanations as to how an event happened or what produced it remain conjectures only, where the evidence is without selective application to any one of them ” (30 Am. Jur. 2d, Evidence, § 1081, p. 229).

The first possibility concerns a complication that arose during the initial operation of implantation. One of the electrodes was shifted twice by the surgeon during this operation in order to secure better position. In doing this shifting, the surgeon was guided by feel, his vision being obscured by a thick layer of epicardial fat.

[188]*188On the record before us, it is clear that submission of this causative possibility to the jury as a basis for breach of warranty was erroneous. As to implied warranties of merchantability and fitness, the issue is whether the pacemaker was fit for the ordinary purpose for which pacemakers were used (merchantability) or whether it was fit for the particular purpose for which it was bought. In this case, the general purpose and specific purpose seem to be identical.

In determining the issue, the basic question is whether the operative contingency encountered by the surgeon was reasonably foreseeable by the manufacturer. However, a jury should not be called upon to answer this question without the benefit of expert, proof (Curtis v. Gano, 26 N. Y. 426; Finn v. Cassidy, 165 N. Y. 584). A pacemaker is a relatively new exotic instrument, knowledge of which is peculiar to the medical profession and its supportive science. Where the product is exotic, newly on the market place, and usable only through the intervention of a highly trained specialist, a finding by the jury, without the benefit of expert opinion as to the expectations of the professional community in purchasing the product, would be highly speculative and presumptuous. The situation is analogous to that where a jury of laymen is asked in a medical malpractice case to determine the issue of negligence simply as an inference from the circumstances (cf. Pipers v. Rosenow, 39 A D 2d 240). Without medical testimony as to whether the inability of the electrode to withstand kinkage caused by a doctor’s excessive manipulation constituted a defect in the electrode, the jury would have no ground upon which to base a finding of breach of warranty. Yet, there was no testimony in the record to this effect. That the breakage was caused by the doctor’s manipulation was left as a possibility without further explanation as to whether this possibility implied that the product was thereby defective.

The same rationale applies to the second possibility. The plaintiff’s own expert testified that sometimes an electrode will shear just from the force of the heart muscle. Yet, there was no testimony to show whether this would indicate that the unit was initially unfit for use. In fact, the plaintiff’s expert testified that the break could occur without any defect in the electrode.

The third possibility was that damage occurred to the pacemaker during its transfer from Montefiore Hospital to Long Island College Hospital, the latter hospital being where the implantation took place. The question is therefore raised as to whether the appellant is responsible if such damage occurred. The plaintiff was billed directly by the appellant for the pace[189]*189maker. At the trial, the parties stipulated that the pacemaker was consigned ” to Montefiore Hospital and subsequently “ requisitioned ” to Long Island College Hospital. During the course of the trial, the plaintiff’s counsel stated that the full nature of the transaction would be proved. However, no further evidence concerning the transaction was ever introduced. Upon this incomplete showing, there was no way that the jury could have fixed responsibility had they determined that the defect, if there was one, was caused after the pacemaker left the appellant’s hands.

Thus, it is clear that any finding by the jury that the first occurrence of pacemaker failure was due to breach of warranty could only have been based on conjecture.

The second occurrence of apparent pacemaker failure occurred in April of 1964, when the first pacemaker failed to penetrate its current to the plaintiff’s heart. Although the jury may reasonably have found that the failure was due to fibrosis, there was no proof in the record that the appellant knew or should have known that fibrosis could have caused the pacemaker to cease proper functioning. Yet, the trial court charged the jury that it was the duty of the appellant to warn of this possibility. Absent any proof that the appellant had or should have had the requisite knowledge, the charge was erroneous, since it was not based on any proven fact

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Wedel Software USA Inc. v. Miracle Channel Assn.
2024 NY Slip Op 31956(U) (New York Supreme Court, New York County, 2024)
Koublani v. Cochlear Limited
E.D. New York, 2021
Shealy v. Boston Scientific Corporation
Superior Court of Delaware, 2021
Mason v. Reed's Inc.
S.D. New York, 2021
Wholey v. Amgen, Inc.
2018 NY Slip Op 6692 (Appellate Division of the Supreme Court of New York, 2018)
Yates v. Ortho-McNeil Pharmaceutical, Inc.
76 F. Supp. 3d 680 (N.D. Ohio, 2015)
Scheinberg v. Merck & Co.
924 F. Supp. 2d 477 (S.D. New York, 2013)
Slowley v. City of New York
33 Misc. 3d 952 (New York Supreme Court, 2011)
Gelber v. Stryker Corp.
788 F. Supp. 2d 145 (S.D. New York, 2011)
Kraft v. Staten Island Boat Sales, Inc.
715 F. Supp. 2d 464 (S.D. New York, 2010)
WESTPORT MARINA, INC. v. Boulay
783 F. Supp. 2d 344 (E.D. New York, 2010)
Meyer v. Alex Lyon & Son Sales Managers & Auctioneers, Inc.
67 A.D.3d 547 (Appellate Division of the Supreme Court of New York, 2009)
Horowitz v. Stryker Corp.
613 F. Supp. 2d 271 (E.D. New York, 2009)
Nealy Ex Rel. Estate of Nealy v. United States Surgical Corp.
587 F. Supp. 2d 579 (S.D. New York, 2008)
Rose v. Am. Tobacco Co.
2004 NY Slip Op 50355(U) (New York Supreme Court, New York County, 2004)
Imperia v. Marvin Windows of New York, Inc.
297 A.D.2d 621 (Appellate Division of the Supreme Court of New York, 2002)
Clarke v. LR SYSTEMS
219 F. Supp. 2d 323 (E.D. New York, 2002)
Gonzalez v. Rutherford Corp.
881 F. Supp. 829 (E.D. New York, 1995)
Harwell v. American Medical Systems, Inc.
803 F. Supp. 1287 (M.D. Tennessee, 1992)

Cite This Page — Counsel Stack

Bluebook (online)
42 A.D.2d 185, 345 N.Y.S.2d 637, 1973 N.Y. App. Div. LEXIS 3789, Counsel Stack Legal Research, https://law.counselstack.com/opinion/friedman-v-medtronic-inc-nyappdiv-1973.